Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions
TLDR
There is not just one solution for the nonadherence problem that fits all patients, and to improve adherence effectively, there is a need for a tailored approach based on the type and cause ofNonadherence and the specific needs of the patient.Abstract:
Background: Nonadherence with medication is a complex and multidimensional health care problem. The causes may be related to the patient, treatment, and/or health care provider. As a consequence, substantial numbers of patients do not benefit optimally from pharmacotherapy, resulting in increased morbidity and mortality as well as increased societal costs. Several interventions may contribute to improved adherence. However, most interventions have only a modest effect. Thus, despite the many efforts made, there has been little progress made as yet in tackling the problem of nonadherence. Methods: This paper summarizes the definitions and taxonomy of adherence with medication, as well as types and causes of nonadherence. In addition, interventions aimed at improvement of adherence are discussed. Conclusion: There is not just one solution for the nonadherence problem that fits all patients. Most interventions to improve adherence are aimed at all patients regardless of whether they are adherent or not. Recently, a number of tailored interventions have been described in the literature. Modern techniques are useful. Electronic pill boxes combined with Short Message Service reminders are specifically designed to improve unintentional adherence and have resulted in an increase in refill adherence in diabetic patients with suboptimal adherence. Tailored Internet interventions are a possibility for influencing patient drug-taking behavior and show promising results. Tailored counseling interventions targeted at the underlying causes of nonadherence seem an attractive method for supporting patients with their use of drugs. However, despite the plausible theoretical framework, data on long-term health effects of the various interventions are not available. To improve adherence effectively, there is a need for a tailored approach based on the type and cause of nonadherence and the specific needs of the patient. © 2013 Hugtenburg et al, publisher and licensee Dove Medical Press Ltd.read more
Citations
More filters
Journal ArticleDOI
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
James Neuberger,Wolf O. Bechstein,Dirk Kuypers,Patrizia Burra,Franco Citterio,Sabina De Geest,Christophe Duvoux,Alan G. Jardine,Nassim Kamar,Bernhard K. Krämer,Herold J. Metselaar,Frederik Nevens,Jacques Pirenne,Manuel Rodríguez-Perálvarez,Didier Samuel,Stefan Schneeberger,Daniel Serón,Pavel Trunecka,Giuseppe Tisone,Teun van Gelder +19 more
TL;DR: In this article, the authors provide specific, practical recommendations, through the discussion of current evidence and best practice, for the management of modifiable risks in those kidney and liver transplant patients who have survived the first postoperative year.
Journal ArticleDOI
Supporting Adherence to Medicines for Long-Term Conditions
TL;DR: The Perceptions and Practicalities Approach (PAPA), a pragmatic framework positing that adherence/nonadherence is essentially a produce of individual motivation and ability, is described and how PAPA can be operationalized is discussed, including the application of theoretical models of illness and treatment representation to address salient adherence-related perceptions.
Journal ArticleDOI
A Review of Medication Adherence Monitoring Technologies
TL;DR: This review focuses on recent advances in the field of technology-based medication adherence approaches and pays particular attention to their technical monitoring aspects, including sensor systems, proximity sensing, vision systems, and combinations of these.
Journal ArticleDOI
Adherence to Antihypertensive Therapy
Erin Peacock,Marie Krousel-Wood +1 more
TL;DR: Research to understand the effects of technology-mediated interventions, mechanisms underlying adherence behavior, and sex-race differences in determinants of low adherence and intervention effectiveness may enhance patient-specific approaches to improve adherence and disease control.
Journal ArticleDOI
Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.
Gabriel S. Tajeu,Shia T. Kent,Ian M. Kronish,Lei Huang,Marie Krousel-Wood,Adam P. Bress,Daichi Shimbo,Paul Muntner +7 more
TL;DR: Low adherence to antihypertensive medication has decreased among Medicare beneficiaries; however, rates of discontinuation and low adherence remain high.
References
More filters
Journal ArticleDOI
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics
Liset van Dijk,Eibert R. Heerdink,Dinesh Somai,Sandra van Dulmen,E. Sluijs,Denise T. D. de Ridder,Anna M G F Griens,Jozien M. Bensing +7 more
TL;DR: Both early dropout and refill nonadherence were highest for antidepressants, followed by antihypertensives, and there was a considerable range between general practices in the proportion of patients who were nonadherent.
Journal ArticleDOI
Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia
TL;DR: Controlling risk factors for poor adherence in combination with patient education that includes direct communication between the health care team and the patient are essential components for maximizing the benefits of TKI therapy.
Journal ArticleDOI
Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior
Annemiek J. Linn,Julia C.M. van Weert,Barbara C. Schouten,Edith G. Smit,Ad A. van Bodegraven,Liset van Dijk +5 more
TL;DR: The PPB-typology provides communication recommendations that are designed to meet patients’ needs and assist providers in the promotion of successful medication intake behavior, and it can be a useful tool for developing effective communication skills training programs.
Ascertaining barriers to compliance: Policies for safe, effective and cost-effective use of medicines in Europe
A. Andrzejczyk,Wendy Clyne,S. De Geest,Jenny Demonceau,Fabienne Dobbels,E.A. Fargher,Dyfrig A. Hughes,Przemyslaw Kardas,Paweł Lewek,Michał Matyjaszczyk,Sarah McLachlan,Val Morrison,C. Msheila,Sahdia Parveen,A. Piaszczynska,Catrin Plumpton,Todd M. Ruppar,Kaat Siebens,John Urquhart,Bernard Vrijens,Simon D. M. White +20 more
TL;DR: The ABC Project’s findings are expected to help health policymakers take right decisions to minimize the negative impact of non-adherence and produce evidence-based policy recommendations for improving patient adherence.